You are here: Industry Insights > Cyclica

News List

Nurosene, Cyclica partner for neurodegenerative disease drug development pharmaceutical-business-review
February 11, 2022
Nurosene, Cyclica partner for neurodegenerative disease drug development.
Luciole Pharmaceuticals and Cyclica Announce Research Collaboration to Accelerate Discovery of Novel Medicines prnasia
October 13, 2021
Luciole Pharmaceuticals, a startup company focused on the discovery and development of small molecules that enhance the repair of oxidative damage to mitochondrial DNA (mtDNA), and Cyclica...
China’s Institute of Materia Medica Partners With Cyclica on Innovative Drug Repurposing for COVID-19 Businesswire
March 06, 2020
The epidemic of COVID-19 remains a prominent healthcare challenge, affecting more than 70 countries and regions over the world. This rapid widespread has made more countries realize the need for international collaboration to address this global concern.
Merck KGaA taps Cyclica for AI-based screening of protein-drug interactions fiercebiotech
December 28, 2018
Merck KGaA has licensed a cloud-based artificial intelligence proteome screening platform from the Toronto-based Cyclica.The yearlong agreement will allow the German biotech to evaluate the mechanisms of action and...
Merck KGaA links with AI firm to iron out side-effects during R&D pharmaphorum
December 11, 2018
Germany’s Merck KGaA has begun a licensing agreement with Canadian pharma R&D company Cyclica using artificial intelligence (AI) to uncover new drug targets and predict any side effects.
Merck partners with Cyclica for AI-based screening of drug targets pharmaceutical-technology
December 11, 2018
Merck has signed an agreement to licence Canadian Cyclica’s cloud-based in-silico proteome screening platform called Ligand Express to support its research efforts......
WuXi AppTec and Cyclica to collaborate on drug discovery efforts fiercebiotech
August 23, 2018
WuXi AppTec’s research service division and Canadian biotech Cyclica announced a partnershipto develop programs looking into the development of small molecule polypharmacology.